Objective: Degenerative cervical myelopathy (DCM) is a degenerative spine disease and the most common cause of spinal cord dysfunction in adults worldwide. The objective of this study is to determine the natural history of DCM by updating the systematic review by Karadimas et al. The specific aims of this review were (1) to describe the natural history of DCM and (2) to determine potential risk factors of disease progression.
Introduction
Degenerative cervical myelopathy (DCM) is a degenerative spine disease and the most common cause of spinal cord dysfunction in adults worldwide. 1 The term DCM encompasses cord compression secondary to osteoarthritic changes to the spine, disc degeneration, ligamentous aberrations, and progressive kyphosis. Patients with DCM may present with a wide range of neurological signs and symptoms, including pain, lower limb spasticity, decreased hand dexterity, hyperreflexia, and sphincter disturbance.
The pattern of progression in DCM is not well defined. Early reports of the natural history suggest that DCM is a relatively benign disorder and that patients are more likely to remain stable over time than to deteriorate. 2 In the most recent systematic review of the literature, there was moderate evidence that 20% to 62% of patients with symptomatic myelopathy will decline by at least 1 point on the Japanese Orthopaedic Association scale if not managed surgically. 3 The objective of this study was to update the systematic review by Karadimas et al 3 that investigated (1) the natural history of DCM and (2) the potential risk factors of disease progression.
Materials and Methods

Electronic Literature Search
An updated search based on a previous protocol 4 was conducted in PubMed and the Cochrane Collaboration library for studies published between November 2012 and February 15, 2015. Inclusion and exclusion criteria for the search were previously published, as well as methods for data abstraction, data analysis, evaluation of study quality, and assessment of the overall strength of evidence.
Results
Study Selection
The updated electronic search yielded 122 new citations (Figure 1 ). An additional 40 citations were identified through directed manual search. One hundred and fifty-seven studies were excluded following title and abstract review, and 5 studies were further investigated. Following full text review, a single study was excluded because all patients underwent surgery for DCM, and another for including nonmyelopathic patients with ossification of the posterior longitudinal ligament (OPLL; Table 1) . 5 Three other studies presented new information relevant to key question 1 and reported the incidence of spinal cord injury and severe disability in patients with DCM. [6] [7] [8] Two retrospective cohort studies used the National Health Insurance Research Database, which contains records for 23 million administered insurants in Taiwan (approximately 99% of the entire population). 7, 8 The first study included 14 140 patients hospitalized for cervical spondylotic myelopathy (CSM) with at least 1 year of follow-up (Table 2) . 8 The second study consisted of 5604 patients with myelopathy secondary to OPLL and at least 3 years of follow-up. 7 A third prospective cohort study reported outcomes on 450 patients with myelopathy secondary to OPLL; however, only 36 were managed conservatively after refusing surgical treatment.
Hospitalization for Spinal Cord Injury
Based on 2 retrospective cohort studies, the incidence rate of hospitalization for spinal cord injury was 13. Table 3 ). The rate of hospitalization for spinal cord injury in patients with DCM from OPLL was significantly higher than the rate observed in a healthy population (0.18 per 1000 person-years; hazard ratio ¼ 32.2; 95% CI ¼ 10.4-99.0; P < .001). 7 These studies both had moderately low risk of bias (Table 4) .
Disability
One large retrospective study evaluated the incidence of severe neurological deficits from spinal cord injury in patients with CSM, including paraplegia, tetraplegia, and incontinence; the reported rate was 3.4 per 1000 person-years. 7 A second small prospective study reported that the risk of being wheelchair bound or bedridden was 66.7% (24/36) in patients with DCM Study design Prospective cohort study P Retrospective cohort study P P Case-control study Case series Patients at similar point in the course of their disease or treatment
P P
Patients followed long enough for outcome to occur
Complete follow-up of 80% P P Controlling for extraneous prognostic factors a P P a Authors must summarize baseline characteristics, and control for those that differ between treatment groups. 
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Global Spine Journal 7(3S) [10] [11] [12] [13] observational studies) that 20% to 62% of patients will deteriorate (at least 1 point on the JOA) 3-6 years after initial assessment. Proportions vary based on definition of deterioration.
High
Risk of bias (1) Nurick Grade change compared with baseline
Very Low There is very low evidence from one small retrospective observational study (N ¼ 76) 14 that a majority of DCM patients will not experience a change on the Nurick over time with nonoperative treatment. Sixty-seven percent of patients were stable, 20% improved, and 13% deteriorated after 8 years.
Low
Inconsistent (1) Spinal cord injury Low There is low-level evidence that the rate of hospitalization for spinal cord injury is 13.9 per 1000 person-years in patients with CSM. 8 The rate is 4. and 4 small retrospective observational studies) 11, [17] [18] [19] that the proportion of patients undergoing surgery following worsening of symptoms increases over time.
The proportion of patients converting to surgery ranges from 4% to 40% over 3 to 7 years, respectively. Low Imprecise (1)
Functional outcome
Activities of daily living
Moderate There is moderate evidence (2 small prospective studies, N ¼ 31 20 and N ¼ 33 21 ) that patients with DCM worsen in performing activities of daily living (ADL) with nonoperative treatment. One study reported 6%, 21%, 28%, and 56% worsening of ADL from baseline values at 1-, 2-, 3-, and 10-years follow-up, respectively.
High
Risk of bias (1) Timed 10-meter walk Very Low There is very low evidence (one small prospective study, N ¼ 33 21 ) that there is no significant difference in 10-meter walking test times between baseline and 1-, 2-, 3-, and 10-years following conservative treatment.
Risk of bias (1); Imprecise (1); Inconsistent (1)
Overall functional status
Very Low There is very low evidence (one small prospective observational study, N ¼ 31 20 ) that the overall functional status improves over time in patients treated conservatively for DCM.
Low
Inconsistent (1) Are there risk factors that affect the progression of DCM?
Neurological outcome Demographic characteristics Age Very Low There is very low evidence to support the association between age at diagnosis and neurological deterioration based on the JOA. One prospective study reported no association using multivariate analysis; 13 one prospective study reported that older age (mean 58 years) before treatment was a positive predictor for neurological improvement (P < .05); 9 and one retrospective study reported that younger age (<52 years) was a positive predictor for neurological improvement using univariate analysis. 17 
Inconsistent (1); Imprecise (1) ) (P < .05) and a higher Pavlov Index (mean 0.9) (P < .05) are associated with improved neurological status (JOA). 9 
High
Other radiological factors
Very Low There is very low evidence (one prospective study using multivariate analysis) that there is no significant association between developmental or dynamic canal factors, high T2WI signal intensity and neurological deterioration (JOA). 
Clinical characteristics Initial level of disability
Very Low There is very low evidence (one prospective 9 and one retrospective 17 observational study) that milder disability before treatment is associated with greater neurological improvement (JOA) (P < .05).
Low
Imprecise (1)
Duration of disease
Very Low There is very low evidence (2 retrospective observational studies) that a shorter duration of symptoms is associated with neurological improvement (JOA) (P ¼ .001). 13, 17 Low Inconsistent (1)
Range of motion Very Low There is very low evidence (one retrospective study) that greater neck range of motion (ROM) (P < .05), greater head ROM (P < .01), and difference between total head and neck ROM (P < .01) are associated with progressively worse neurological condition (JOA). 
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Global Spine Journal 7(3S) secondary to OPLL (Table 3) . 6 This study had moderately high risk of bias (Table 4) .
Evidence Summary
The rate of hospitalization due to spinal cord injury was 4.8 per 1000 person-years in patients with DCM secondary to OPLL and 13.9 per 1000 person-years in patients with CSM. The rate of severe disability in DCM patients with OPLL was 3.4 per 1000 person-years. The strength of evidence for these estimates was Low (Table 5 ).
Conclusions
The results of this update indicate that the presence of OPLL or CSM may increase a patient's risk of severe disability and hospitalization for spinal cord injury. Although these findings are unlikely to directly influence management strategies, patients should be counseled of the possibility of spinal cord injury when discussing the benefits and risks of various treatment options.
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